DE2901730A1 - Kristallisationsverfahren - Google Patents

Kristallisationsverfahren

Info

Publication number
DE2901730A1
DE2901730A1 DE19792901730 DE2901730A DE2901730A1 DE 2901730 A1 DE2901730 A1 DE 2901730A1 DE 19792901730 DE19792901730 DE 19792901730 DE 2901730 A DE2901730 A DE 2901730A DE 2901730 A1 DE2901730 A1 DE 2901730A1
Authority
DE
Germany
Prior art keywords
sodium
cefuroxime
aqueous solution
crystallization medium
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19792901730
Other languages
German (de)
English (en)
Other versions
DE2901730C2 (en, 2012
Inventor
Harry Carson Stables
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE2901730A1 publication Critical patent/DE2901730A1/de
Application granted granted Critical
Publication of DE2901730C2 publication Critical patent/DE2901730C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19792901730 1978-01-17 1979-01-17 Kristallisationsverfahren Granted DE2901730A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB188178 1978-01-17

Publications (2)

Publication Number Publication Date
DE2901730A1 true DE2901730A1 (de) 1979-07-19
DE2901730C2 DE2901730C2 (en, 2012) 1992-10-01

Family

ID=9729694

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19792901730 Granted DE2901730A1 (de) 1978-01-17 1979-01-17 Kristallisationsverfahren

Country Status (7)

Country Link
US (1) US4298732A (en, 2012)
JP (1) JPS54117492A (en, 2012)
CH (1) CH638218A5 (en, 2012)
DE (1) DE2901730A1 (en, 2012)
FR (1) FR2414509A1 (en, 2012)
IT (1) IT1162442B (en, 2012)
NL (1) NL189762C (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024441A1 (en) * 1997-11-10 1999-05-20 Dsm N.V. Crystallization of beta-lactam compounds

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341777A (en) * 1979-09-10 1982-07-27 Glaxo Group Limited Cephalosporin antibiotic
JPS6011491A (ja) * 1983-03-04 1985-01-21 Shionogi & Co Ltd セフアロチンナトリウムの結晶性凍結乾燥粉末の製造法
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
JPH0288824U (en, 2012) * 1988-12-27 1990-07-13
KR100396464B1 (ko) * 2000-12-14 2003-09-02 씨제이 주식회사 세푸록심의 나트륨염을 함유하는 약학적 조성물의 안정화방법
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
CN100384853C (zh) * 2004-05-10 2008-04-30 河北张药股份有限公司 替卡西林钠的合成方法
CN101475579B (zh) * 2009-01-20 2011-02-09 广州白云山天心制药股份有限公司 一种稳定的头孢呋辛钠及其制备方法
CN102295653A (zh) * 2010-06-28 2011-12-28 广州白云山制药股份有限公司广州白云山化学制药厂 头孢呋辛钠的一步法回收制备方法
CN102617604A (zh) * 2012-02-24 2012-08-01 天津大学 一种耦合反应结晶制备头孢呋辛钠的方法
CN103374019B (zh) * 2012-04-12 2016-08-03 珠海保税区丽珠合成制药有限公司 一种头孢呋肟钠的制备方法
CN103102357B (zh) * 2013-02-21 2016-01-13 广东立国制药有限公司 一种头孢呋辛钠的合成方法
CN112979082B (zh) * 2021-03-01 2023-01-03 安徽金轩科技有限公司 一种呋喃铵盐生产废水回收再利用工艺

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2164399A1 (de) * 1970-12-24 1972-11-02 Eli Lilly and Co., Indianapolis, Ind. (V.StA.) Gewinnung von Cephalothinsalzen
DE2439880B2 (de) * 1973-08-21 1979-02-22 Glaxo Laboratories Ltd., Greenford, Middlesex (Grossbritannien) (6R, 7R)-3-Carbamoyloxymethyl-7- [2-(fur-2-yl)-2methoxyiminoacetamido] -ceph-S-em^carbonsäure und Verfahren zur ihrer Herstellung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3974153A (en) * 1971-05-14 1976-08-10 Glaxo Laboratories Limited 7-Hydrocarbonoxy imino-acetamido-3-carbamoyloxy methylceph-3-em-4 carboxylic acids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2164399A1 (de) * 1970-12-24 1972-11-02 Eli Lilly and Co., Indianapolis, Ind. (V.StA.) Gewinnung von Cephalothinsalzen
DE2439880B2 (de) * 1973-08-21 1979-02-22 Glaxo Laboratories Ltd., Greenford, Middlesex (Grossbritannien) (6R, 7R)-3-Carbamoyloxymethyl-7- [2-(fur-2-yl)-2methoxyiminoacetamido] -ceph-S-em^carbonsäure und Verfahren zur ihrer Herstellung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Römpps Chemie-Lexikon, 1973, 277, 1875, 1876 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024441A1 (en) * 1997-11-10 1999-05-20 Dsm N.V. Crystallization of beta-lactam compounds

Also Published As

Publication number Publication date
NL7900356A (nl) 1979-07-19
FR2414509B1 (en, 2012) 1983-07-08
IT1162442B (it) 1987-04-01
NL189762C (nl) 1993-07-16
JPS638115B2 (en, 2012) 1988-02-19
IT7947641A0 (it) 1979-01-15
JPS54117492A (en) 1979-09-12
US4298732A (en) 1981-11-03
FR2414509A1 (fr) 1979-08-10
NL189762B (nl) 1993-02-16
DE2901730C2 (en, 2012) 1992-10-01
CH638218A5 (de) 1983-09-15

Similar Documents

Publication Publication Date Title
DE2901730A1 (de) Kristallisationsverfahren
CH648037A5 (de) Imidazo-rifamycin-derivate mit antibakterieller wirksamkeit.
DE2504108C2 (de) Verfahren zur Gewinnung und Reinigung von Pullulan
DE1166199B (de) Verfahren zur Herstellung von 7-Aminocephalosporansaeurederivaten
DE2614669C2 (de) Gamma-kristalline wasserfreie Form von 7-(D-alpha-Formyloxy-alpha-phenylacetamido)-3-(1-methyl-1H-tetrazol-5- ylthiomethyl)-3-cephem-4-natriumcarboxylat und Verfahren zu ihrer Herstellung
DE2431483B2 (de) Verfahren zur Herstellung von Alkalioder Ammoniumsalzen von Insulin
DE1966849C3 (de) 1 zu 1 Komplex von Cephalosporin C und Zink in kristalliner Form
DE858699C (de) Verfahren zur Herstellung von Estern des Penicillins mit substituierten Aminoalkoholen bzw. deren Salzen oder quaternaeren Ammoniumverbindungen
DE606857C (de) Verfahren zur Darstellung von Dihydroresorcin
DE731601C (de) Verfahren zur Einfuehrung von Dicarbonsaeureradikalen in teilweise veresterte Cellulose
DE945407C (de) Verfahren zur Gewinnung und Reindarstellung von Bacitracin
DE933450C (de) Verfahren zur Herstellung eines neuen Salzes von Penicillin G
DD213219A5 (de) Verfahren zur herstellung von kristallinem natrium-cefoperazon
DE1967320C2 (de) Verfahren zur Herstellung von wasserfreien 6-(1-Aminocycloalkylcarboxamido)-penicillansäuren
DE620300C (de) Verfahren zur Herstellung acetonloeslicher hochviscoser Celluloseester niederer Fettsaeuren durch Behandlung mit halogenhaltigen Phosphorverbindungen
DE657106C (de) Verfahren zur Darstellung von N-Methyl-C, C-allylisopropylbarbitursaeure
AT234903B (de) Verfahren zur Herstellung von Kanamycin-N, N'-dimethansulfonsäure
DE863248C (de) Verfahren zur Reinigung von Penicillin und seinen Salzen
DE947334C (de) Verfahren zur Herstellung von Insulinpraeparaten mit einem Zinkgehalt von 0,5% und darunter
AT231072B (de) Verfahren zur Reinigung von Polymyxinen
DE972336C (de) Verfahren zur Gewinnung von stabilen, besonders fuer die Oraltherapie geeigneten Penicillinen
DE917604C (de) Verfahren zur Herstellung von neuen schwerloeslichen Penicillinsalzen
AT200264B (de) Verfahren zur Herstellung von neuen Desinfektionsmitteln
AT206590B (de) Verfahren zur Herstellung von neuen am Indolstickstoff substituierten Derivaten der Lysergsäure-Reihe
DE1570014C (de) Tetramcotinsaureester des 2,2,6,6 Tetrahydroxymethylcyclohexanols und Ver fahren zu seiner Herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ZUMSTEIN SEN., F., DR. ASSMANN, E., DIPL.-CHEM. DR

D2 Grant after examination
8364 No opposition during term of opposition